Medtronic completes $1.1B acquisition of Intersect ENT

Spinal Tech

Medtronic completed its acquisition of Intersect ENT.

The acquisition grows Medtronic's ENT portfolio with the Propel and Sinuva product lines, according to a May 13 news release. Intersect ENT's subsidiary company, Fiagon, was not included in the acquisition.

The $1.1 billion acquisition was announced in August.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Whitepapers